Overview

Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
This study wants to investigate the hemodynamic changes in cardiopatic patients undergoing major non cardiac surgery, during and after the continuous infusion of levosimendan or dobutamine.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Azienda Policlinico Umberto I
Treatments:
Dobutamine
Simendan
Criteria
Inclusion Criteria:

- EF < 40%, no liver and renal disfynction, chronic cardiopathy

Exclusion Criteria:

- acute coronary syndrome, life expectation <30 days, hemodialysis, ventricular
tachycardia/ventricular fibrillation